npj Precision Oncology

Article	Citations
An automated deep learning pipeline for EMVI classification and response prediction of rectal cancer using baseline MRI: a multi-centre study	311
KMT2C inactivation leads to PTEN downregulation and tolerance to DNA damage during cell cycle progression	156
MYSM1 promotes lung adenocarcinoma progression via TRAF2/3-mediated activation of MAPK and non-canonical NF-κB pathways	134
BRAF v600E–mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study	126
Imaging and AI based chromatin biomarkers for diagnosis and therapy evaluation from liquid biopsies	123
Sub-regional radiomics combining multichannel 2-dimensional or 3-dimensional deep learning for predicting neoadjuvant chemo-immunotherapy response in esophageal squamous cell carcinoma: a multicenter	121
Improved prediction of MAPKi response duration in melanoma patients using genomic data and machine learning	117
Multi-modal characterization of metabolic and immune gene clusters in adrenocortical carcinoma treatment	109
Development and testing of a polygenic risk score for breast cancer aggressiveness	108
Developing survival prediction models in colorectal cancer using epigenome-wide DNA methylation data from whole blood	90
Author Correction: An automated deep learning pipeline for EMVI classification and response prediction of rectal cancer using baseline MRI: a multi-centre study	74
Circulating tumor DNA in ALK-positive anaplastic large cell lymphoma: a proof-of-concept study	69
Genome-wide analyses reveals an association between invasive urothelial carcinoma in the Shetland sheepdog and NIPAL1	68
Exosome- transported FER inhibitor suppresses progression of diffuse large B-cell lymphoma via regulating AJUBA/Hippo axis	67
The dynamic immune behavior of primary and metastatic ovarian carcinoma	66
Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes	61
Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP	60
Constitutional mismatch repair deficiency mimicking Lynch syndrome is associated with hypomorphic mismatch repair gene variants	60
Artificial intelligence-driven prediction of lymph node metastasis in T1 esophageal squamous cell carcinoma using whole slide images	58
A protein-encoding CCDC7 circular RNA inhibits the progression of prostate cancer by up-regulating FLRT3	58
Analyses of canine cancer mutations and treatment outcomes using real-world clinico-genomics data of 2119 dogs	57
Grading of lung adenocarcinomas with simultaneous segmentation by artificial intelligence (GLASS-AI)	57
A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada	56
Patient-level proteomic network prediction by explainable artificial intelligence	55
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates	53

Tumor break load quantitates structural variant-associated genomic instability with biological and clinical relevance across cancers	52
Interferon signaling and ferroptosis in tumor immunology and therapy	50
Mucin-1: a promising pan-cancer therapeutic target	50
Barriers and opportunities in pancreatic cancer immunotherapy	50
Erigoster B targeting DECR1 induces ferroptosis of breast cancer cells via promoting phosphatidylcholine/arachidonic acid metabolism	49
Enhanced efficacy of ipilimumab plus nivolumab in angiogenic subtypes of metastatic clear-cell renal cell carcinoma	47
Multiregional transcriptomic profiling provides improved prognostic insight in localized non-small cell lung cancer	47
ECM-based molecular subtypes define prognostic, EMT status, and therapeutic diversity in IDH-mutant gliomas	46
Establishing predictive machine learning models for drug responses in patient derived cell culture	46
Discovery of prognostic lncRNAs in colorectal cancer using spatial transcriptomics	46
Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma	45
Pan-cancer molecular tumor board experience with biomarker-driven precision immunotherapy	45
Machine learning model for predicting tertiary lymphoid structures and treatment response in triple-negative breast cancer	45
Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab	43
Single-cell landscape of bronchoalveolar immune cells in patients with immune checkpoint inhibitor-related pneumonitis	43
PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127+ and KLRG1+ CD8 T cells	43
Collagen disorder architecture features are associated with clinical, molecular, genetic factors and survival outcomes in colon cancer	43
Prolonged response to dual immune checkpoint blockade in patients with advanced solid tumors: a case series	42
Genomic and transcriptomic analyses identify distinctive features of triple-negative inflammatory breast cancer	41
TRIM65 regulates glucose metabolic reprogramming to promote glioma cell proliferation via ubiquitination and degradation of AMPK	40
Stage-dependent spatial distribution and prognostic value of CD8+ tissue-resident memory T cells in NSCLC	40
A universal immunohistochemistry analyzer for generalizing AI-driven assessment of immunohistochemistry across immunostains and cancer types	38
Real-world experience of Molecular Tumour Boards for clinical decision-making for cancer patients	37
m6A reader IGF2BP2-stabilized lncRNA LHX1-DT inhibits renal cell carcinoma (RCC) cell proliferation and invasion by sponging miR-590-5p	37
First-in-human prospective trial of sonobiopsy in high-grade glioma patients using neuronavigation-guided focused ultrasound	36
User-centered design approach to visualize PROMs for molecular tumor boards	36
Multi-omics machine learning to study host-microbiome interactions in early-onset colorectal cancer	36
Self-supervised attention-based deep learning for pan-cancer mutation prediction from histopathology	36
Relationship among DDR gene mutations, TMB and PD-L1 in solid tumour genomes identified using clinically actionable biomarker assays	35
An international multi-institutional validation study of the algorithm for prostate cancer detection and Gleason grading	35
A core driver gene set identified based on geMER reveals its potential driver mechanism in pan-cancer	35
Targeting Nrf2/PHKG2 axis to enhance radiosensitivity in NSCLC	35
Author Correction: Imaging and AI based chromatin biomarkers for diagnosis and therapy evaluation from liquid biopsies	35
Tumor fraction-based prognostic tool for cancer patients referred to early phase clinical trials	34
Leveraging patient derived models of FGFR2 fusion positive intrahepatic cholangiocarcinoma to identify synergistic therapies	33
HER3 targeting augments the efficacy of panobinostat in claudin-low triple-negative breast cancer cells	33
AI-driven eyelid tumor classification in ocular oncology using proteomic data	33
A large-scale, multi-centre validation study of an AI-empowered blood-based test for multi-cancer early detection	33
Enhancing adoptive cell therapy: future strategies for immune cell radioprotection in neuro-oncology	32
Machine learning algorithms for predicting glioma patient prognosis based on CD163+FPR3+ macrophage signature	32
Deciphering associations between three RNA splicing-related genetic variants and lung cancer risk	31
Selpercatinib combination with the mitochondria-targeted antioxidant MitoQ effectively suppresses RET–mutant thyroid cancer	31
In-depth inference of transcriptional regulatory networks reveals NPM1 as a therapeutic ribosomal regulator in MYC-amplified medulloblastoma	31
Novel molecular subtypes of METex14 non-small cell lung cancer with distinct biological and clinical significance	31
Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancers	30
The SMARCA4R1157W mutation facilitates chromatin remodeling and confers PRMT1/SMARCA4 inhibitors sensitivity in colorectal cancer	30
Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibition	30
Compound heterozygous MSH3 germline variants and associated tumor somatic DNA mismatch repair dysfunction	30
ML-based sequential analysis to assist selection between VMP and RD for newly diagnosed multiple myeloma	29
Progress in personalized immunotherapy for patients with brain metastasis	29

Predicting ROS1 and ALK fusions in NSCLC from H&E slides with a two-step vision transformer approach	28
Perfusion-based ex vivo culture of frozen ovarian cancer tissues with preserved tumor microenvironment	28
A complex phylogeny of lineage plasticity in metastatic castration resistant prostate cancer	28
Role of large language models in the multidisciplinary decision-making process for patients with renal cell carcinoma: a pilot experience	28
EPAS1 increases SDHA to inhibit proliferation of multiple myeloma cells by restoring TCA Cycle	28
ChemoID-guided therapy improves objective response rate in recurrent platinum-resistant ovarian cancer randomized clinical trial	27
ALK fusions in the pan-cancer setting: another tumor-agnostic target?	27
Colorectal cancer risk stratification on histological slides based on survival curves predicted by deep learning	27
A multimodal fusion system predicting survival benefits of immune checkpoint inhibitors in unresectable hepatocellular carcinoma	27
Deep learning-based quantification of eosinophils and lymphocytes shows complementary prognostic effects in colorectal cancer patients	27
Homologous recombination deficiency signatures in gastrointestinal and thoracic cancers correlate with platinum therapy duration	26
Unlocking the potential of TIGIT in enhancing therapeutic strategies for acute myeloid leukemia through combined azacitidine therapy	26
Efficacy of PARP inhibitor therapy after targeted BRAF/MEK failure in advanced melanoma	26
Plasma proteomic biomarkers predict therapeutic responses in advanced biliary tract cancer patients receiving Camrelizumab plus the GEMOX treatment	26
Potential of pre-diagnostic metabolomics for colorectal cancer risk assessment or early detection	26
Activation of CD44/PAK1/AKT signaling promotes resistance to FGFR1 inhibition in squamous-cell lung cancer	25
Augmented reality microscopy to bridge trust between AI and pathologists	25
Targeting tumoral heterogeneity in lung cancer: a novel, CT-texture-guided targeted biopsy approach with exome sequencing	25
High clinical actionability of a pan-cancer tissue-based combined DNA and RNA next generation sequencing assay in a diverse Asian population	25
MDM2 inhibition is associated with the emergence of TP53-altered clonal hematopoiesis	25
CNTNAP4 signaling regulates osteosarcoma disease progression	24
Artificial intelligence-based epigenomic, transcriptomic and histologic signatures of tobacco use in oral squamous cell carcinoma	24
Multiclass machine learning models for molecular subtype identification of pediatric low-grade glioma using bi-institutional MRIs for precision medicine	24
A patient-designed tissue-engineered model of the infiltrative glioblastoma microenvironment	24
Artificial intelligence-based assessment of PD-L1 expression in diffuse large B cell lymphoma	23
PUM1-TRAF3 fusion protein activates non-canonical NF-κB signaling via rescued NIK in biliary tract cancer	23
A multi-cancer early detection blood test using machine learning detects early-stage cancers lacking USPSTF-recommended screening	23
Multi-output prediction of dose–response curves enables drug repositioning and biomarker discovery	23
Ligand-receptor interactions combined with histopathology for improved prognostic modeling in HPV-negative head and neck squamous cell carcinoma	23
Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer	23
Cancer-related cells and oncosomes in the liquid biopsy of pancreatic cancer patients undergoing surgery	23
Complete morphologic response to gilteritinib in ALK-rearranged acute myeloid leukemia	23
Personalized prediction of anticancer potential of non-oncology drugs through learning from genome derived molecular pathways	23
Germline pathogenic variants in DNA repair pathways: a key feature in a significant subset of translocation-associated sarcomas	22
Genetic and oncogenic features of RASGRF fusions	22
Potential utility of risk stratification for multicancer screening with liquid biopsy tests	22
LINE1 insertion into the NACC2 locus disrupts the HDM2 axis and activates lung oncogenic signaling	22
Multicenter radio-multiomic analysis for predicting breast cancer outcome and unravelling imaging-biological connection	22
Personalized circulating tumor DNA dynamics inform survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancer	22
APOE-high myeloid cells are uniquely associated with metastatic intrathoracic lymph nodes obtained by EBUS-TBNA in primary lung cancer	21
Functional cure with single agent olutasidenib in relapsed IDH1/NPM1 co-mutated AML	21
Predicting colorectal cancer survival by combined c-reactive protein and tumor immune score	21
Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancers	21
ARHGAP4/MYH9/β-catenin/c-Jun positive feedback loop promotes colorectal cancer stemness	21
Co-clinical trial targeting ER, FGFR and CDK4/6 in resistant hormone-positive breast cancer with FGFR alterations	21
Development and interpretation of a multimodal predictive model for prognosis of gastrointestinal stromal tumor	21
Author Correction: A targetable OSGIN1–AMPK–SLC2A3 axis controls the vulnerability of ovarian cancer to ferroptosis	21
Striking efficacy of a vaccine targeting TOP2A for triple-negative breast cancer immunoprevention	21
HER2 expression in cervical squamous cell carcinoma: high prevalence of HER2-low/ultralow and spatiotemporal heterogeneity across tumor evolution	21
Use of PSMA PET/CT to detect prostate cancer metastatic to a preexisting thyroid nodule	20
Complete response to fifth-line anti-PD-1 rechallenge in fumarate hydratase-mutated papillary renal cell carcinoma	20
Bladder cancer diagnostic and prognostic models from DNA methylation by multi algorithm machine learning	20
Novel paediatric case of a spinal high-grade astrocytoma with piloid features in a patient with Noonan Syndrome	20
High TGF-β signature predicts immunotherapy resistance in gynecologic cancer patients treated with immune checkpoint inhibition	20
Multi-omics analyses reveal interactions between GREM1+ fibroblasts and SPP1+ macrophages in gastric cancer	20
Clock pathway inhibitor overcomes tumor immune-exclusion via regulation of fibrocyte differentiation	20
Exceptional response to the ATR inhibitor, camonsertib, in a patient with ALT+ metastatic melanoma	20
The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients	20
GD2: hopes and challenges for the treatment of pediatric patients with tumors of the central nervous system	20
HDAC6 facilitates LUAD progression by inducing EMT and enhancing macrophage polarization towards the M2 phenotype	19
Author Correction: Predicting the tumor microenvironment composition and immunotherapy response in non-small cell lung cancer from digital histopathology images	19
Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab Deruxtecan	19
Tackling FGFR3-driven bladder cancer with a promising synergistic FGFR/HDAC targeted therapy	19
Opportunities and challenges for patient-derived models of brain tumors in functional precision medicine	19
Design of self-assembled micelles based on natural dual-targeting strategies and evaluation of their anti-liver cancer effects as drug delivery systems	19
Development of potent antibody drug conjugates against ICAM1+ cancer cells in preclinical models of cholangiocarcinoma	19
Tertiary lymphoid structures potentially promote immune checkpoint inhibitor response in SMARCB1-deficient medullary renal cell carcinoma	19
Whole-genome analysis of an aggressive metastatic pancreatic solid pseudopapillary neoplasm	19
Imaging immunity in patients with cancer using positron emission tomography	19
Predicting survival in prospective clinical trials using weakly-supervised QSP	19
NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology	18
Progress and challenges of artificial intelligence in lung cancer clinical translation	18
Towards precision radiation oncology: endocrine therapy response as a biomarker for personalization of breast radiotherapy	18
Fast, accurate, and racially unbiased pan-cancer tumor-only variant calling with tabular machine learning	18
Machine learning-driven multi-targeted drug discovery in colon cancer using biomarker signatures	18
Evaluating cell culture reliability in pediatric brain tumor primary cells through DNA methylation profiling	18
Element-specific estimation of background mutation rates in whole cancer genomes through transfer learning	18
A review of machine learning methods for cancer characterization from microbiome data	18
Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer	18
Impact of TP53 mutations in Triple Negative Breast Cancer	18

A destabilizing Y891D mutation in activated EGFR impairs sensitivity to kinase inhibition	18
Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer	17
Single-cell transcriptome analysis identifies MIF as a novel tumor-associated neutrophil marker for pancreatic ductal adenocarcinoma	17
Integrative whole slide image and spatial transcriptomics analysis with QuST and QuPath	17
DNA methylation at quantitative trait loci (mQTLs) varies with cell type and nonheritable factors and may improve breast cancer risk assessment	17
Multi-omics analysis reveals NNMT as a master metabolic regulator of metastasis in esophageal squamous cell carcinoma	17
Multi-omics analysis deciphers intercellular communication regulating oxidative stress to promote oral squamous cell carcinoma progression	17
Plasma epigenomic profiling reveals treatment-emergent squamous transformation in prostate cancer	17
Biallelic EPCAM deletions induce tissue-specific DNA repair deficiency and cancer predisposition	16
Multimodal spatial proteomic profiling in acute myeloid leukemia	16
Integrative molecular analyses define correlates of high B7-H3 expression in metastatic castrate-resistant prostate cancer	16
Deep learning-based detection and semi-quantitative model for spread through air spaces (STAS) in lung adenocarcinoma	16
An appraisal of genetic testing for prostate cancer susceptibility	16
Single-cell transcriptome sequencing reveals spatial distribution of IL34+ cancer-associated fibroblasts in hepatocellular carcinoma tumor microenvironment	16
Prediction and analysis of tumor infiltrating lymphocytes across 28 cancers by TILScout using deep learning	16
A comprehensive analysis of minimally differentially methylated regions common to pediatric and adult solid tumors	16
Single-cell analysis of gastric pre-cancerous and cancer lesions reveals cell lineage diversity and intratumoral heterogeneity	15
Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors	15
Integration of pre-treatment computational radiomics, deep radiomics, and transcriptomics enhances soft-tissue sarcoma patient prognosis	15
A phase II trial of mTORC1/2 inhibition in STK11 deficient non small cell lung cancer	15
Defining the extracellular matrix for targeted immunotherapy in adult and pediatric brain cancer	15
Single-cell spatial architectures associated with clinical outcome in head and neck squamous cell carcinoma	15
Methylation cytometric pretreatment blood immune profiles with tumor mutation burden as prognostic indicators for survival outcomes in head and neck cancer patients on anti-PD-1 therapy	15
Spatial tumor immune microenvironment phenotypes in ovarian cancer	15
Precision immuno-oncology approach for four malignant tumors in siblings with constitutional mismatch repair deficiency syndrome	15
Secrets of DNA-PKcs beyond DNA repair	15
HAPIR: a refined Hallmark gene set-based machine learning approach for predicting immunotherapy response in cancer patients	15
CAR-macrophages in solid tumors: promise, progress, and prospects	14
Latent class analysis-derived classification improves the cancer-specific death stratification of molecular subtyping in colorectal cancer	14
High risk clear cell renal cell carcinoma microenvironments contain protumour immunophenotypes lacking specific immune checkpoints	14
RadGLO: an interactive platform for radiomic feature analysis and prognostic modeling in glioma	14
Identification of novel prognostic and predictive biomarkers in salivary duct carcinoma via comprehensive molecular profiling	14
Revealing neuroendocrine transformation in gynecological cancers through genomic analysis	14
Emerging innovations in theranostics for pancreatic neuroendocrine tumors	14
Author Correction: An interpretable machine learning system for colorectal cancer diagnosis from pathology slides	14
Collision of germline POLE and PMS2 variants in a young patient treated with immune checkpoint inhibitors	14
Accurate prediction of disease-free and overall survival in non-small cell lung cancer using patient-level multimodal weakly supervised learning	14
Cell graph neural networks enable the precise prediction of patient survival in gastric cancer	14
All models are wrong and yours are useless: making clinical prediction models impactful for patients	14
GLMP promotes EGFR-TKI resistance by activating autophagy and RhoA pathway in non-small cell lung cancer	14
Author Correction: Naltriben promotes tumor growth by activating the TRPM7-mediated development of the anti-inflammatory M2 phenotype	14
Complete response to alectinib in ALK-fusion metastatic salivary ductal carcinoma	14
Trans-ancestry transcriptome-wide association and functional studies to uncover novel susceptibility genes and therapeutic targets for colorectal cancer	14
Survival-inferred fragility of statistical significance in phase III oncology trials	14
Integrating histopathology and transcriptomics for spatial tumor microenvironment profiling in a melanoma case study	14
Upregulation of POLE and proficient DNA repair are features of CIC::DUX4 sarcomas	14
Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology	13
A morphometric signature to identify ductal carcinoma in situ with a low risk of progression	13
Bayesian risk prediction model for colorectal cancer mortality through integration of clinicopathologic and genomic data	13
Locoregional tumor burden and risk of mortality in metastatic breast cancer	13
Comprehensive analysis of targetable mutations and tumor microenvironment in urachal cancer	13
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression	13
Neoadjuvant therapy-induced immune dynamics and myeloid-associated resistance in advanced head and neck cancer	13
Prediction of early-stage melanoma recurrence using clinical and histopathologic features	13
MC1R signaling through the cAMP-CREB/ATF-1 and ERK-NFκB pathways accelerates G1/S transition promoting breast cancer progression	13
Adaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancer	13
Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities	13
Integrative machine learning-driven prognosis and immunotherapy stratification via lactylation-associated gene in ovarian cancer	13
Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patients	13
Multimodal analysis suggests differential immuno-metabolic crosstalk in lung squamous cell carcinoma and adenocarcinoma	12
Biopsy image-based deep learning for predicting pathologic response to neoadjuvant chemotherapy in patients with NSCLC	12
Enhancing decision-making in glioblastoma surgery through an explainable human-AI collaboration: an international multicenter model development and external validation study	12
A multiparameter liquid biopsy approach allows to track melanoma dynamics and identify early treatment resistance	12
Proximity of immune and tumor cells underlies response to BRAF/MEK-targeted therapies in metastatic melanoma patients	12
Intraoperative margin assessment for basal cell carcinoma with deep learning and histologic tumor mapping to surgical site	12
Integrative bioinformatics analysis and experimental validation identify CHEK1 as an unfavorable prognostic biomarker related to immunosuppressive phenotypes in soft tissue sarcomas	12
Integrative analysis reveals prognostic value of cuproptosis and copper hemostasis related genes in immunotherapy for non-small cell lung cancer	12
Applying a multi-task and multi-instance framework to predict axillary lymph node metastases in breast cancer	12
Development of a deep learning model for cancer diagnosis by inspecting cell-free DNA end-motifs	12
Identification of breast cancer subtypes and drug response prediction through forward and reverse translation	12
A deep learning model, NAFNet, predicts adverse pathology and recurrence in prostate cancer using MRIs	12
A single-cell based precision medicine approach using glioblastoma patient-specific models	12
M6A-ALKBH5-dependent RBMS3-AS3 down-regulation suppresses ferroptosis to promote lung adenocarcinoma progression through HNRNPDL/ZEB1/GPX4 axis	12
Molecular landscape of ERBB2 alterations in 3000 advanced NSCLC patients	12
Multi-omics analysis unveils immunosuppressive microenvironment in the occurrence and development of multiple pulmonary lung cancers	12
Illuminating the future of precision cancer surgery with fluorescence imaging and artificial intelligence convergence	12
Unsupervised generative AI for enhancing brain tumor segmentation in multi-center, incomplete real-world data scenarios	12
Androgen receptor splice variant expression and prostate cancer recurrence after salvage therapy	12
A multi-modal deep learning model for prediction of Ki-67 for meningiomas using pretreatment MR images	12
Pharmacogenomic discovery of genetically targeted cancer therapies optimized against clinical outcomes	12
Deep learning predicts patients outcome and mutations from digitized histology slides in gastrointestinal stromal tumor	12
Sequencing of cerebrospinal fluid cell-free DNA facilitated early differential diagnosis of intramedullary spinal cord tumors	11
Exploring mitochondrial ribosomal protein S12 as a novel target for non-small cell lung cancer	11
Multi-cancer detection of circulating tumor cells by targeting oncofetal chondroitin sulfate	11
Addressing racial and ethnic disparities in AACR project GENIE	11
Extreme wrinkling of the nuclear lamina is a morphological marker of cancer	11
Single-cell transcriptomic analysis of HPV-related multiphenotypic sinonasal carcinoma uncovers MYB-HPV association	11
Comprehensive single-cell RNA analysis reveals intertumoral microenvironment heterogeneity and hub niche of carcinogenesis in thyroid cancer	11
Super multiple primary lung cancers harbor high-frequency BRAF and low-frequency EGFR mutations in the MAPK pathway	11
The evolving landscape of antibody-drug conjugates (ADCs) for treatment of prostate cancer	11
The landscape of therapeutic vulnerabilities in EGFR inhibitor osimertinib drug tolerant persister cells	11
Just Add Data: automated predictive modeling for knowledge discovery and feature selection	11
Naltriben promotes tumor growth by activating the TRPM7-mediated development of the anti-inflammatory M2 phenotype	11
Pathologic complete response to KEYNOTE522 and HER2-directed therapy for synchronous TNBC and HER2+ breast cancer	11
A promptable CT foundation model for solid tumor evaluation	11